Fei Wu is a fourth-year medical student from Laval University, Québec City. He is completing an MD-MS in neuroscience double pathway and aspires to become a clinical scientist in neurology. Under the supervision of Dr. Robert Jr Laforce, behavioral neurologist, and Dr. Ali Dirani, retinal surgeon, his research work consists of developing novel retinal biomarkers for a rare form of atypical dementias: the language variant of Alzheimer's disease, also known as the logopenic variant of primary progressive aphasias.
Sessions in which Mr. Fei Wu participates
Friday 20 June, 2025
Author’s Name(s): Fei Wu, Monica Lavoie, Mélanie Hébert, Robert Laforce Jr, Ali DiraniAuthor’s Disclosure Block: Fei Wu, none; Monica Lavoie, none; Mélanie Hébert, none; Robert Laforce Jr, none; Ali Dirani, noneAbstract BodyPurpose: The logopenic variant primary progressive aphasia (lvPPA) is a rare neurodegenerative disorder which predominantly affects language functions. In 86% of lvPPA cases, the underlying pathology is a...
Sessions in which Mr. Fei Wu attends
Friday 20 June, 2025
Our lively Exhibition Hall provides an opportunity for you to reconnect with industry partners to explore the latest treatment options and medical devices available.
Author’s Name(s): Printha Wijesinghe, Amir Hosseini, Justin Haynes, Ian Mackenzie, Veronica HirschReinshagen, Ging-Yuek Hsiung, Benjamin Spiller, Brian Wadzinski, Wellington Pham, Joanne Matsubara Author’s Disclosure Block: Printha Wijesinghe, none; Amir Hosseini, none; Justin Haynes, none; Ian Mackenzie, none; Veronica Hirsch-Reinshagen, none; Ging-Yuek Hsiung, none; Benjamin Spiller, none; Brian Wadzinski, none; Wellington Pham, none; Joanne Mat...